UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046584 |
|---|---|
| Receipt number | R000053144 |
| Scientific Title | The risk factor of the locomotive syndrome: systematic review and meta-analysis. |
| Date of disclosure of the study information | 2022/01/07 |
| Last modified on | 2023/01/09 11:32:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The risk factor of the locomotive syndrome: systematic review and meta-analysis.
Acronym
The risk factor of the locomotive syndrome: systematic review and meta-analysis.
Scientific Title
The risk factor of the locomotive syndrome: systematic review and meta-analysis.
Scientific Title:Acronym
The risk factor of the locomotive syndrome: systematic review and meta-analysis.
Region
| Japan |
Condition
Condition
locomotive syndrome
Classification by specialty
| Orthopedics | Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To identify a risk factor of the locomotive syndrome.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Odds ratio, Risk ratio
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Evaluation of the locomotive syndrome was performed.
(2) Odds ratio/risk ratio were calculated.
Key exclusion criteria
N.A.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Yoshitaka |
| Middle name | |
| Last name | Iwamoto |
Organization
Hiroshima University
Division name
Graduate School of Biomedical and Health Sciences
Zip code
7348553
Address
1-2-3, Kasumi, Minami-ku, Hiroshiima, Japan
TEL
082-257-5417
iwamo10@hiroshima-u.ac.jp
Public contact
Name of contact person
| 1st name | Yoshitaka |
| Middle name | |
| Last name | Iwamoto |
Organization
Hiroshima University
Division name
Graduate School of Biomedical and Health Sciences
Zip code
7348553
Address
1-2-3 Kasumi Minami-Ku Hiroshima Japan
TEL
0822575417
Homepage URL
iwamo10@hiroshima-u.ac.jp
Sponsor or person
Institute
Hiroshima University
Institute
Department
Personal name
Funding Source
Organization
Hiroshima University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Hiroshima University
Address
1-2-3 Kasumi Minami-Ku Hiroshima Japan
Tel
0822575417
iwamo10@hiroshima-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 01 | Month | 07 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2022 | Year | 01 | Month | 07 | Day |
Date of IRB
| 2022 | Year | 01 | Month | 07 | Day |
Anticipated trial start date
| 2022 | Year | 01 | Month | 07 | Day |
Last follow-up date
| 2022 | Year | 01 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The following electronic databases were searched in November 2021: PubMed, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus, Web of Science, and Itsushi web.
Management information
Registered date
| 2022 | Year | 01 | Month | 07 | Day |
Last modified on
| 2023 | Year | 01 | Month | 09 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053144
